Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
Nature|November 4, 2016
LKB1 loss links serine metabolism to DNA methylation and tumorigenesisFilippos Kottakis, Brandon N Nicolay, Ahlima Roumane, et al.
British Journal of Cancer|July 23, 2021
Fibroblast growth factor receptor 3 alterations and response to immune checkpoint inhibition in metastatic urothelial cancer: a real world experienceTracy L Rose, William H Weir, Gregory M Mayhew, et al.
Plos One|May 17, 2012
Differential pathogenesis of lung adenocarcinoma subtypes involving sequence mutations, copy number, chromosomal instability, and methylationMatthew D Wilkerson, Xiaoying Yin, Vonn Walter, et al.
The Journal of Molecular Diagnostics : JMD|May 25, 2013
Prediction of lung cancer histological types by RT-qPCR gene expression in FFPE specimensMatthew D Wilkerson, Jason M Schallheim, D Neil Hayes, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 17, 2016
Germline Analysis from Tumor-Germline Sequencing Dyads to Identify Clinically Actionable Secondary FindingsBryce A Seifert, Julianne M O'Daniel, Krunal Amin, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 31, 2023
Noncanonical HPV carcinogenesis drives radiosensitization of head and neck tumorsTravis P Schrank, Aditi Kothari, William H Weir, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 21, 2010
Lung squamous cell carcinoma mRNA expression subtypes are reproducible, clinically important, and correspond to normal cell typesMatthew D Wilkerson, Xiaoying Yin, Katherine A Hoadley, et al.
JCO Precision Oncology|September 11, 2020
Comprehensive Molecular Characterization of Urachal Adenocarcinoma Reveals Commonalities With Colorectal Cancer, Including a Hypermutable PhenotypeJordan Kardos, Sara E Wobker, Michael E Woods, et al.
Cancer Research Communications|September 23, 2022
Tumor Cell Extrinsic Synaptogyrin 3 Expression as a Diagnostic and Prognostic Biomarker in Head and Neck CancerRyan M Murphy, Jason Tasoulas, Alessandro Porrello, et al.
Gynecologic Oncology|March 8, 2025
A randomized phase II/III study of paclitaxel/carboplatin/metformin versus paclitaxel/carboplatin/placebo as initial therapy for measurable stage III or IVA, stage IVB, or recurrent endometrial cancer: An NRG oncology/GOG studyVictoria L Bae-Jump, Michael W Sill, Paola A Gehrig, et al.
Pageof 4